Latest Strategy News

GTN Limited has finalised a $43.85 million capital return, distributing $0.23 per share to shareholders. The company awaits an Australian Tax Office ruling to clarify tax implications for investors.

Equity Story Group has raised $200,000 through a strategic share placement at a premium, signaling investor confidence as it expands its wealth management services.

TasFoods announces plans to divest its premium artisan cheese brand Pyengana Dairy, aiming to refocus capital on its poultry supply chain. The sale, potentially to a major shareholder-backed fund, marks a strategic pivot for the company.

Australian Gold and Copper Ltd has reported robust silver-gold mineralisation from initial drilling at the Achilles deposit, with diamond drilling now underway to explore deeper extensions. Geological insights highlight a key stratigraphic marker aiding future targeting.

Orbminco Limited has announced the upcoming resignation of Managing Director Ralf Kriege, effective November 7, 2025, marking a significant leadership change for the copper and gold explorer.

Livium Ltd and Mineral Resources Ltd have formalised a 50 – 50 joint venture to commercialise the innovative LieNA® lithium processing technology, aiming to license it globally despite current market headwinds.

Litchfield Minerals Limited has launched a $1.5 million capital raising to fast-track exploration at its Northern Territory copper-zinc projects, including the advanced Oonagalabi asset. Recent drilling and geophysical surveys highlight promising mineralisation and near-term growth potential.

Scentre Group has announced an ordinary dividend of AUD 0.08815 per security for the half-year ended 30 June 2025, payable on 29 August. The dividend is fully unfranked and includes a Dividend Reinvestment Plan with no discount.

Credit Intelligence Limited has issued a profit warning revealing a reduced loss of approximately A$4.5 million for FY25, down from A$12.5 million the previous year, driven by strategic divestments and a revenue decline.

Island Pharmaceuticals has raised $350,000 through an options exercise by substantial shareholder MWP Partners, reinforcing confidence in its antiviral drug development pipeline.

Reef Casino Trust has received a revised $184.3 million takeover offer from Morris Group, intensifying a competitive bidding process with Iris Cairns Property. Unitholders are advised to hold off on decisions as the Independent Board Committee evaluates the proposals.

Syntara Limited has received FDA guidance recommending a Phase 2 controlled trial for its lead drug amsulostat in myelofibrosis, setting the stage for a pivotal Phase 3 study. The company is poised to refine its clinical strategy while advancing a diverse pipeline with key data milestones ahead.